Name (Synonyms) | Correlation | |
---|---|---|
drug44 | 50 mg/mL Virazole Wiki | 1.00 |
drug1613 | No intervention Wiki | 0.24 |
Name (Synonyms) | Correlation | |
---|---|---|
D000163 | Acquired Immunodeficiency Syndrome NIH | 0.58 |
D015658 | HIV Infections NIH | 0.41 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This study is a Phase 1, open label, non-randomized, two-arm interventional clinical trial to evaluate the safety and efficacy of Virazole® in hospitalized adult patients who have tested positive for COVID-19 and, as a result, have significant respiratory distress (PaO2/FiO2 ratio <300 mmHg).
Description: The severity rating will be based on the ordinal scale of clinical status as follows: Death. Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO). Hospitalized, on non-invasive ventilation or high flow oxygen devices. Hospitalized, requiring supplemental oxygen. Hospitalized, not requiring supplemental oxygen. Not hospitalized, limitation on activities. Not hospitalized, no limitations on activities.
Measure: Change in the clinical status severity (CSS) rating from the first dose date up to the completion of treatment Time: 7 days